Apavac, a Simple Autologous Vaccination Process (AV) Associated with Clinical Efficacy in 56 Patients (pts) Having Cancer (C) and 11 Pts Having Hematological Malignancies (HM)
Conclusions. APAVAC is a simple method for AV with high clinical impact in very bad situations. It could be used in combination with other therapy and for residual disease control. Further clinical studies are planned in solid C as well as in HM.DisclosuresRouquet: URODELIA: Employment. Frayssinet: URODELIA: Employment.
Source: Blood - Category: Hematology Authors: Rossi, J.-F., Rouquet, N., Frayssinet, P. Tags: 703. Adoptive Immunotherapy Source Type: research
More News: Bladder Cancer | Bone Cancers | Cancer | Cancer & Oncology | Cancer Vaccines | Clinical Trials | Colon Cancer | Colorectal Cancer | Employment | Endometrial Cancer | Gastric (Stomach) Cancer | Gastroenterology | Head and Neck Cancer | Hematology | Immunotherapy | Kidney Cancer | Leukemia | Lidoderm | Liver | Lung Cancer | Lymphoma | Melanoma | Myelodysplastic Syndrome | Myeloma | Pain | Renal Cell Carcinoma | Sarcomas | Skin Cancer | Study | Urology & Nephrology | Vaccines
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024